Skip to content
Open access

Hashimoto’s thyroiditis influences tumor cell states and intratumoral microbiota in papillary thyroid carcinoma

Aug 2026 · iScience · Vol 29, pp. 117167 · 0 citations · 42 references
Medicine

TL;DR

It is suggested that Hashimoto’s thyroiditis reshapes both epithelial transcriptional states and the intratumoral microbial environment, potentially contributing to a less aggressive tumor phenotype.

Abstract

Summary Hashimoto’s thyroiditis is associated with reduced lymph node metastasis in papillary thyroid carcinoma, suggesting that the autoimmune microenvironment may influence tumor progression. We utilized single-cell RNA sequencing and intratumoral 16S ribosomal RNA gene sequencing to investigate malignant epithelial cell states and microbial features in PTC with and without Hashimoto’s thyroiditis. Tumors with Hashimoto’s thyroiditis exhibited malignant epithelial populations enriched for innate immune signaling programs and showed increased intratumoral microbial diversity with reduced abundance of several Gram-negative bacteria, particularly Pseudomonas. Within the Hashimoto’s thyroiditis subgroup, lymph node metastasis was associated with increased Gram-negative bacterial abundance. Functional experiments further showed that Pseudomonas-derived lipopolysaccharide enhanced thyroid cancer cell migration in vitro and in vivo. These findings suggest that Hashimoto’s thyroiditis reshapes both epithelial transcriptional states and the intratumoral microbial environment, potentially contributing to a less aggressive tumor phenotype.

Read PDF

Similar papers

Open access Jul 2026

Coexistence of thyroid sclerosing mucoepidermoid carcinoma with eosinophilia and mucosa-associated lymphoid tissue lymphoma in Hashimoto thyroiditis: a case report

This case suggests that chronic inflammatory conditions associated with Hashimoto’s thyroiditis may have contributed to the tumorigenesis of both the epithelial and lymphoid components.

Yutaka Nakamura, T. Murata, Yuichi Fujita et al. · 0 citations
Open access Aug 2026

Myeloid landscape of BRAF-mutant papillary thyroid cancer and thyroiditis

The data suggest that LT in thyroid cancer is associated with enhanced antigen presentation and fewer features of pro-tumourigenic innate immune activity, which suggest new mechanisms to target immune treatments in PTC refractory to other therapies.

S. Perampalam, M. Gild, Sey Adwoa Amoakowa et al. · 0 citations
Open access Jul 2026

Single-cell sequencing profiling of intratumoral heterogeneity and immunosuppressive microenvironment in primary thyroid cancer and lymph node metastases

This study comprehensively maps the coevolution of malignant thyrocyte plasticity and the immunosuppressive metastatic niche in thyroid cancer and provides a robust molecular rationale for developing next-generation immunotherapeutic strategies tailored to thyroid cancer.

Shu-hang Xu, Yaorong Su, Senmin Zhang et al. · 0 citations
Jul 2026

Developing an epithelial signature for prognosis of papillary thyroid carcinoma.

Findings indicate that a malignant epithelial program defined by single-cell analysis can be translated into a four-gene signature associated with epithelial aggressiveness and TME remodeling in PTC, although its clinical utility requires validation in independent cohorts.

Zi-Yuan Wang, Shu Xu, Xuechen Chen et al. · 0 citations
Open access Jul 2026

Clinical significance of coexisting Hashimoto's thyroiditis in differentiated thyroid cancer: a retrospective cohort study.

Hashimoto's Thyroiditis is associated with smaller tumor size and a lower prevalence of lymph node metastasis in patients with Differentiated Thyroid Cancer, but HT is not an independent predictor of pathological tumor aggressiveness after adjustment for tumor size.

Syed Haseeb Zia, Ying Li, Wen-Wen Zhang et al. · 0 citations
Open access Aug 2026

Coexistent Hashimoto’s thyroiditis modulates lymph node metastasis burden in papillary thyroid carcinoma: a single-center study in South China

Concomitant HT is associated with a reduced metastatic burden rather than an increased prevalence of CLNM in patients with papillary thyroid carcinoma (PTC), and the necessity of prophylactic central lymph node dissection warrants individualized assessment combining clinical data and intraoperative observations to avoi...

Tianyu Gan, Dongyuan Gan, Guansheng Liao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.